Standout Papers

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery 2009 2026 2014 2020 673
  1. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery (2009)
    Bin‐Bing S. Zhou, Haiying Zhang et al. Nature Reviews Drug Discovery

Immediate Impact

24 by Nobel laureates 17 from Science/Nature 70 standout
Sub-graph 1 of 20

Citing Papers

Designing antibodies as therapeutics
2022 Standout
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
2022 Standout

Works of Marc Damelin being referenced

Abstract 1773: Tumor cell-intrinsic STING pathway activation leads to robust induction of Type III Interferons and contributes to the anti-tumor activity elicited by STING agonism
2021
Evolving Strategies for Target Selection for Antibody-Drug Conjugates
2015

Author Peers

Author Last Decade Papers Cites
Marc Damelin 1200 695 211 244 37 1.8k
Nicolson Gl 810 600 197 339 43 1.7k
Anna Maria Gasparri 1101 688 263 156 44 2.0k
Martin Hagedorn 1492 437 255 461 42 2.2k
Gur Pines 1207 648 268 164 29 1.7k
Pinaki Bose 989 691 117 344 41 1.8k
Yan Wu 2056 567 133 366 33 2.4k
Marina Cardó‐Vila 989 371 424 237 31 1.7k
Giuseppe Roscilli 1043 553 130 363 47 1.7k
Qian Zhan 943 727 94 261 35 1.6k
Giordano Caponigro 1995 664 99 287 45 2.6k

All Works

Loading papers...

Rankless by CCL
2026